Investment
Features
FeesSafety
Academy
More
Pluang+

Malicious bots made up 43% of holiday e-commerce traffic in 2025, nearly matching human shoppers.

Market News
23 Jun 2026
GlobeNewsWire
View Source
Neutral
pluang ai news

Radware's 2026 E-Commerce Bot Threat Report reveals that during the 2025 holiday shopping season, malicious bots accounted for 43% of e-commerce website traffic, nearly matching the 46% generated by human shoppers. This marks a significant increase from 31% the previous year, driven largely by AI tools that enable less sophisticated attackers to launch automated attacks. The report highlights a surge in various attack types like account takeovers and fake registrations, with many attacks occurring even before sales events. As AI-powered automation grows, online retailers face increasing challenges distinguishing legitimate users from malicious bots, signaling a need for advanced security measures moving forward.

More News

Health plan cuts machine-readable file production from 45 days to under 24 hours with TALON integration

Health plan cuts machine-readable file production from 45 days to under 24 hours with TALON integration

A regional nonprofit health plan reduced its Transparency in Coverage machine-readable file (MRF) production time from 45 days to less than 24 hours by integrating TALON's platform directly with its claims administration system. This eliminated a com...

Others
Neutral
1 hour ago
ASUS launches new durable Chromebooks CM15 and CM32 with long battery life and Google AI features in the US

ASUS launches new durable Chromebooks CM15 and CM32 with long battery life and Google AI features in the US

ASUS has introduced two new Chromebooks in the US market: the budget-friendly CM15 laptop and the versatile CM32 Detachable 2-in-1 device. Both run on the MediaTek Kompanio 540 processor, offer up to 12 hours of battery life, and feature military-gra...

Others
Bullish
2 hours ago
Slate Medicines appoints Mark W. Hahn to board to boost migraine drug development.

Slate Medicines appoints Mark W. Hahn to board to boost migraine drug development.

Slate Medicines, a biotech firm focused on migraine treatments, has appointed Mark W. Hahn to its Board of Directors. Hahn brings over 25 years of experience in life sciences, including leading companies through financial milestones and FDA approvals...

Company Fundamentals
Bullish
3 hours ago
Klarna's growth driven by strong financing, low-cost funding, and expanding customer base despite market volatility risks.

Klarna's growth driven by strong financing, low-cost funding, and expanding customer base despite market volatility risks.

Klarna benefits from maturing financing cohorts, low-cost deposit funding, and prudent risk management, leading to increased transaction margins and net interest income. This supports their growth strategy, reflected in accelerating gross merchandise...

Analyst Insights
Bullish
4 hours ago
Goldman Sachs posts strong Q2 FY2026 with 38% earnings growth and $31B raised in private credit.

Goldman Sachs posts strong Q2 FY2026 with 38% earnings growth and $31B raised in private credit.

Goldman Sachs reported robust Q2 FY2026 results, with net earnings growing at an annualized rate of 38%. The firm raised $31 billion in private credit and saw a 130% year-over-year surge in equity underwriting revenues, driven by major deals and IPO ...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App